Monday, May 19, 2008 5:53:00 AM PDT | VentureDeal Staff
Novasys is developing novel therapies for the treatment
of female pelvic disorders. The
company's initial focus is on treatments for female stress urinary incontinence.Investors in the round included Versant Ventures, Three Arch Partners, Skyline Ventures, Delphi Ventures, Alloy Ventures, Affinity Capital, Onset Ventures, J.P. Morgan Partners and Invesco Private Capital.The company said it would use the funds to bring its Renessa
nonsurgical treatment to women suffering from stress urinary incontinence.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
VentureDeal is a database that provides the latest information about venture capital, venture-backed technology companies, venture capital firms and transactions in the United States.
Learn More »
Deals & News
Email Sign Up
© 2013 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.